Search research articles
Contact Us
Filters
Showing results (1321-1330 of 1,460) with videos related to
Page
of 146
Sort By:
Plos One
|
August 23, 2011
A phase IIA randomized clinical trial of a multiclade HIV-1 DNA prime followed by a multiclade rAd5 HIV-1 vaccine boost in healthy adults (HVTN204)
Gavin J Churchyard, Cecilia Morgan, Elizabeth Adams, et al.
The Lancet. Infectious Diseases
|
April 30, 2021
Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study
Cristina Menni, Kerstin Klaser, Anna May, et al.
Immunity
|
September 9, 2023
Multivalent antigen display on nanoparticle immunogens increases B cell clonotype diversity and neutralization breadth to pneumoviruses
Sebastian Ols, Klara Lenart, Rodrigo Arcoverde Cerveira, et al.
Nature Structural & Molecular Biology
|
August 2, 2016
Iterative structure-based improvement of a fusion-glycoprotein vaccine against RSV
M Gordon Joyce, Baoshan Zhang, Li Ou, et al.
Science Translational Medicine
|
October 16, 2015
Prefusion F-specific antibodies determine the magnitude of RSV neutralizing activity in human sera
Joan O Ngwuta, Man Chen, Kayvon Modjarrad, et al.
Medrxiv : the Preprint Server for Health Sciences
|
March 3, 2021
Racial and ethnic differences in COVID-19 vaccine hesitancy and uptake
Long H Nguyen, Amit D Joshi, David A Drew, et al.
The Journal of Infectious Diseases
|
February 16, 2017
Higher T-Cell Responses Induced by DNA/rAd5 HIV-1 Preventive Vaccine Are Associated With Lower HIV-1 Infection Risk in an Efficacy Trial
Holly E Janes, Kristen W Cohen, Nicole Frahm, et al.
Clinical and Experimental Immunology
|
September 3, 2015
Safety, pharmacokinetics and neutralization of the broadly neutralizing HIV-1 human monoclonal antibody VRC01 in healthy adults
J E Ledgerwood, E E Coates, G Yamshchikov, et al.
BMJ Nutrition, Prevention & Health
|
July 26, 2021
Modest effects of dietary supplements during the COVID-19 pandemic: insights from 445 850 users of the COVID-19 Symptom Study app
Panayiotis Louca, Benjamin Murray, Kerstin Klaser, et al.
Biorxiv : the Preprint Server for Biology
|
November 24, 2025
Human Coronavirus HKU1 Neutralizing Monoclonal Antibodies Target Diverse Epitopes Within and Around the TMPRSS2 Receptor Binding Site
Lingshu Wang, Jeswin Joseph, Sheena Vasquez, et al.
Page
of 146
Search research articles
Search
Showing results (1321-1330 of 1,460) with videos related to
Sort By:
Page
of 146
Plos One
|
August 23, 2011
A phase IIA randomized clinical trial of a multiclade HIV-1 DNA prime followed by a multiclade rAd5 HIV-1 vaccine boost in healthy adults (HVTN204)
Gavin J Churchyard, Cecilia Morgan, Elizabeth Adams, et al.
The Lancet. Infectious Diseases
|
April 30, 2021
Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study
Cristina Menni, Kerstin Klaser, Anna May, et al.
Immunity
|
September 9, 2023
Multivalent antigen display on nanoparticle immunogens increases B cell clonotype diversity and neutralization breadth to pneumoviruses
Sebastian Ols, Klara Lenart, Rodrigo Arcoverde Cerveira, et al.
Nature Structural & Molecular Biology
|
August 2, 2016
Iterative structure-based improvement of a fusion-glycoprotein vaccine against RSV
M Gordon Joyce, Baoshan Zhang, Li Ou, et al.
Science Translational Medicine
|
October 16, 2015
Prefusion F-specific antibodies determine the magnitude of RSV neutralizing activity in human sera
Joan O Ngwuta, Man Chen, Kayvon Modjarrad, et al.
Medrxiv : the Preprint Server for Health Sciences
|
March 3, 2021
Racial and ethnic differences in COVID-19 vaccine hesitancy and uptake
Long H Nguyen, Amit D Joshi, David A Drew, et al.
The Journal of Infectious Diseases
|
February 16, 2017
Higher T-Cell Responses Induced by DNA/rAd5 HIV-1 Preventive Vaccine Are Associated With Lower HIV-1 Infection Risk in an Efficacy Trial
Holly E Janes, Kristen W Cohen, Nicole Frahm, et al.
Clinical and Experimental Immunology
|
September 3, 2015
Safety, pharmacokinetics and neutralization of the broadly neutralizing HIV-1 human monoclonal antibody VRC01 in healthy adults
J E Ledgerwood, E E Coates, G Yamshchikov, et al.
BMJ Nutrition, Prevention & Health
|
July 26, 2021
Modest effects of dietary supplements during the COVID-19 pandemic: insights from 445 850 users of the COVID-19 Symptom Study app
Panayiotis Louca, Benjamin Murray, Kerstin Klaser, et al.
Biorxiv : the Preprint Server for Biology
|
November 24, 2025
Human Coronavirus HKU1 Neutralizing Monoclonal Antibodies Target Diverse Epitopes Within and Around the TMPRSS2 Receptor Binding Site
Lingshu Wang, Jeswin Joseph, Sheena Vasquez, et al.
Page
of 146